The DEA (the US agency that controls which drugs are legal and at what level) is very unlikely to start any formal process to reclassify psilocybin (magic mushrooms) or ibogaine (a plant-based psychedelic) before November 11, 2026. Even though several US states have been pushing to make ibogaine available to veterans, that state-level pressure alone isn't enough to force the federal government's hand. Federal review only gets triggered after large-scale clinical trials finish and the health department formally recommends a change.
State pressure doesn't trigger federal review absent completed pivotal trials and an HHS recommendation. This is anchored to a live, specific development (state ibogaine-veteran momentum) rather than pure evergreen boilerplate.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →